7XO2
Minor polymorph in alpha-synuclein fibril seeded by cerebrospinal fluid from a mid-to-late stage (mid-PD-4) Parkinson's disease patient
Summary for 7XO2
Entry DOI | 10.2210/pdb7xo2/pdb |
EMDB information | 33334 |
Descriptor | Alpha-synuclein (1 entity in total) |
Functional Keywords | amyloid fibril, protein fibril |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 6 |
Total formula weight | 86856.65 |
Authors | |
Primary citation | Fan, Y.,Sun, Y.,Yu, W.,Tao, Y.,Xia, W.,Liu, Y.,Zhao, Q.,Tang, Y.,Sun, Y.,Liu, F.,Cao, Q.,Wu, J.,Liu, C.,Wang, J.,Li, D. Conformational change of alpha-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson's disease. Structure, 31:78-, 2023 Cited by PubMed Abstract: α-Synuclein (α-syn) has been shown to form various conformational fibrils associated with different synucleinopathies. But whether the conformation of α-syn fibrils changes during disease progression is unclear. Here, we amplified α-syn aggregates from the cerebrospinal fluid (CSF) of patients with Parkinson's disease (PD) staged in preclinical PD (pre-PD), middle- to late-stage PD (mid-PD), and late-stage PD (late-PD). Our results show that α-syn fibrils derived from the late-PD patient are most potent in inducing endogenous α-syn aggregation in primary neurons, followed by the mid-PD and pre-PD fibrils. By using cryo-electron microscopy, we further determined the high-resolution structures of the CSF-amplified fibrils. The structures exhibit remarkable differences in a minor but significant population of conformational species in different staged samples. Our work demonstrates structural and pathological differences between α-syn fibrils derived from PD patients at a spectrum of clinical stages, which suggests potential conformational transition of α-syn fibrils during the progression of PD. PubMed: 36513068DOI: 10.1016/j.str.2022.11.013 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3 Å) |
Structure validation
Download full validation report